Revenue
2017
2018
2019
2020
2021
2022
2023
2024
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $940.2M | $1.24B | $854.7M | $419.8M | $1.21B | $914.7M | $600.0M | $513.4M | $684.3M | $846.5M |
| Research & development | $10.5M | — | — | — | — | — | — | — | — | — |
| Operating expenses | $623.5M | $661.2M | $671.7M | $726.7M | $708.9M | $744.1M | $698.5M | $541.4M | $533.4M | $515.3M |
| Operating income | $1.00B | $969.7M | $294.3M | −$281.6M | $534.3M | $195.6M | −$74.6M | $13.4M | $208.2M | $352.0M |
| EBITDAderived | $1.17B | $1.19B | $516.9M | $63.4M | — | — | — | — | — | — |
| Net income | $870.8M | $858.0M | $203.3M | −$338.8M | $473.2M | $112.2M | −$110.1M | $1.4M | $204.0M | $350.3M |
| Basic EPSper diluted share | $4.44 | $4.25 | $1.01 | -$1.68 | $2.25 | $0.52 | -$0.57 | $0.01 | $1.29 | $2.25 |
| Diluted EPSper diluted share | $4.44 | $4.25 | $1.01 | -$1.68 | $2.25 | $0.52 | -$0.57 | $0.01 | $1.29 | $2.22 |